#2 - A biomaterial-based vaccine
Release Date:
In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells. GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab. Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/ Support the showThanks for listening! Let’s stay in touch: Tweet us at @ImmunoTalks Share our episodes on LinkedIN and Instagram Email us at contact@acir.org
#2 - A biomaterial-based vaccine